Verdane invests in Axoniq, Dawn Health, Frameo and XCI
The investor will support go-to-market, data, finance and talent initiatives across the European software portfolio.
Takeaways
- Axoniq, Dawn Health, Frameo and XCI is a Portfolio of four European software, digital health and cybersecurity companies developed by Trifork Labs.
- Verdane and Axoniq, Dawn Health, Frameo and XCI are classified as a secondary transaction.
- The.
Verdane acquired ownership stakes in four technology businesses from Trifork Labs, the venture-investment division of listed software company Trifork Group.
The portfolio includes event-sourcing software company Axoniq, digital health company Dawn Health, WiFi photo-frame software provider Frameo and communication-intelligence cybersecurity company XCI.
Verdane will own the businesses alongside Trifork Group and their management teams.
The investor said it will support go-to-market, data, finance and talent initiatives and may increase its stakes over time.
Financial terms were not disclosed.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.